Leading players operating in the global market for thawing system include Sartorius Aktiengesellschaft, General Electric Company, Cardinal Health, Inc., Helmer, Inc., Barkey GmbH & Co. KG, Cytotherm Lp, and BioCision, LLC.
Thawing systems are basically used for defrosting biological samples in diagnostic centers, biobanks, pharmaceutical companies, and biotechnology. Thawing falls under the primary biopharmaceutical manufacturing process. Thawing systems includes thaw bags and containers for process development. Thawing systems are highly beneficial for R&D purposes as they reduce the need of large amount of sample
Global Thawing Systems Market: Overview
Demand for thawing system is primarily driven by its increasing use in the biopharmaceutical industry. Those biopharmaceutical companies involved in drug making require thawing systems for storing and transporting pharmaceutical products. In addition, factors such as sterile designs and short process cycles have resulted in increase of thawing systems application in end-user industries. A number of bio-repositories all over the world are investing heavily in expanding their storage capacities. Moreover, thawed cells are also finding application in treatment and analysis of disorders such as diabetes and cancer.
Small- & medium-sized vendors continue to exhibit low adoption owing funds shortage.
High cost of automation is expected to inhibit the growth of the market during the forecast period. As per the latest report published by Transparency Market Research (TMR), the global market for thawing system will witness a CAGR of more than 10% during the forecast period (2017-2026), the global thawing system market revenues is expected to the reach close to US$ 350 Mn by 2026-end.
Request For Discount On This Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=36629
No comments:
Post a Comment